| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3477c5bf9bdce4d05056075c82cbd08c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_922648709b12882d20fd08abff100afc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_882ff2a249aee0b6762ca630785b65b2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 |
| filingDate |
2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb9f5f9119fc13bedc6fb6f9fc3f992b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f29a9bfc9cf142cd5f673a88f49e611f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f9102ab76e3eceed2fb2c4fa16ddeaf |
| publicationDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006030549-A1 |
| titleOfInvention |
Paricalcitol(zemplar) capsule controls secondary hyperparathyroidism (SHPT) in CKD stage 5 patients |
| abstract |
Oral paricalcitol for sustained reduction of parathyroid hormone in dialysis patients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033529-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006009425-A1 |
| priorityDate |
2003-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |